No Prescription |
 |
 | ||
|
BELOC ZOK Lopressor |
|
| ||
No Prescription » Prescription Drugs 2 » BELOC ZOK Lopressor Product Origin: EU (Turkey) This product is able to be sourced and supplied at excellent prices because of favourable cross border currency conversions. All products are authentic brand names and will include a product information insert in English. Medical Information: Beloc Zok tablets are indicated for the treatment of hypertension. They may be used alone or in combination with other antihypertensive agents. Beloc Zok is indicated in the long-term treatment of angina pectoris. This group of medicines is known as beta-adrenergic blocking agents beta-blocking agents or more commonly beta-blockers. Beta-blockers are used in the treatment of high blood pressure (hypertension). Some beta-blockers are also used to relieve angina (chest pain) and in heart attack patients to help prevent additional heart attacks. Beta-blockers are also used to correct irregular heartbeat prevent migraine headaches and treat tremors. They may also be used for other conditions as determined by your doctor. Beta-blockers work by affecting the response to some nerve impulses in certain parts of the body. As a result they decrease the heart's need for blood and oxygen by reducing its workload. They also help the heart to beat more regularlyBelok Zok ampuls and tablets are indicated in the treatment of hemodynamically stable patients with definite or suspected acute myocardial infarction to reduce cardiovascular mortality. Treatment with intravenous Belok can be initiated as soon as the patient's clinical condition allows. Metoprolol a type of medication known as a beta blocker is used in the treatment of high blood pressure angina pectoris (chest pain usually caused by lack of oxygen to the heart due to clogged arteries) and heart attack. When prescribed for high blood pressure it is effective when used alone or in combination with other high blood pressure medications. Beta blockers decrease the force and rate of heart contractions thereby reducing the demand for oxygen and lowering blood pressure. Occasionally doctors prescribe Lopressor for the treatment of aggressive behavior prevention of migraine headache and relief of temporary anxiety. An extended-release form of metoprolol called Toprol-XL is prescribed for high blood pressure angina and heart failure. Buy BELOC ZOK Lopressor and other Prescription Drugs 2 products online at Medstore. Buy Online at Medstore - Click Here!
About BELOC ZOK Lopressor: Product Type: Prescription Drugs 2 BELOC ZOK ( Lopressor Betaloc Topral XR Generic Metoprolol ) BELOC ZOK (Lopressor Betaloc Topral XR Generic Metoprolol) Lopressor Betaloc Topral XR Generic Metoprolol 100mg 20 Tabs 25mg 20 Tablets 50mg Lopressor Betaloc Topral XR Generic Metoprolol BELOC ZOK
View more Prescription Drugs 2 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
